Supernus price target raised to $63 from $46 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Supernus (SUPN) to $63 from $46 and keeps an Overweight rating on the shares. The firm updated its model for ONAPGO to factor in a faster cadence of patients on therapy that slightly increases its peak sales potential. Cantor believes there may be even more upside beyond its ONAPGO estimates at this time, the analyst tells investors in a research note.